HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,417-1,428 of 4,505
Drug study icon
CompletedEUCTR 2006-005734-20

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Flexible Dose Paliperidone ER in the Treatment of Subjects with Schizoaffective Disorder

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
SchizophreniaHistorical research record
Countries
Bulgaria
Sponsor
Janssen L.P.
Drug study icon
CompletedEUCTR 2006-003475-13

A SIXTEEN-WEEK, MULTI-CENTER, OPEN-LABEL STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF SWITCHING FROM QUETIAPINE TO ZIPRASIDONE IN SUBJECTS DIAGNOSED WITH SCHIZOPHRENIA OR SCHIZOAFFECT...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
SchizophreniaHistorical research record
Countries
Germany, Greece
Sponsor
Pfizer Pharma GmbH
Drug study icon
CompletedEUCTR 2009-012031-15

The switch study - efficacy of early antipsychotic switch versus maintenance in patients with schizophrenia poorly responding to two weeks of antipsychotic treatment

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
SchizophreniaHistorical research record
Countries
Germany, Romania
Sponsor
Technische Universitaet Muenchen, vertreten durch das Klinikum rechts der Isar
Behavioral study icon
CompletedNCT02085447

A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness

Official study title

A Concierge Model of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAL-C) in Individuals With Schizophrenia at Risk for Treatment Non-adherence and for Homelessness

This study has finished and is no longer accepting participants.

In Cleveland
SchizophreniaBehavioural studyAges 18+
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.